India  

India reports 25,467 Covid cases | US grants full approval to Pfizer | Oneindia News

Video Credit: Oneindia - Duration: 02:01s - Published
India reports 25,467 Covid cases | US grants full approval to Pfizer | Oneindia News

India reports 25,467 Covid cases | US grants full approval to Pfizer | Oneindia News

India recorded 25,467 new Covid-19 cases and 354 deaths in the 24 hours ending 8 am Tuesday.

In other news, US FDA granted full approval to Pfizer BioNTech's Covid 19 vaccine.

#Covid19 #Pfizer #Vaccine


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Earmark separate isolation areas for Omicron-hit: Govt

In the wake of the detection of Omicron cases in some states, the Centre has asked their governments to earmark separate isolation areas for all patients..
IndiaTimes
PM pays tribute to former 'fine colleague' Allegra Stratton [Video]

PM pays tribute to former 'fine colleague' Allegra Stratton

Boris Johnson pays tribute to his former spokesperson Allegra Stratton, who he describes as a "fine colleague". The prime minister also says "there can be no excuse" for the video which emerged showing Stratton and Downing Street aides joking over a Christmas party that was allegedly held during Covid lockdown. Report by Blairm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:09Published
What are the new Covid restrictions under Plan B? [Video]

What are the new Covid restrictions under Plan B?

Boris Johnson has announced new Covid restrictions in a bid to curb the spread of Omicron. Plan B comes in response to a surge of cases, with 568 currently confirmed. Report by Burnsla. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 02:22Published
Boris Johnson announces move to Covid Plan B [Video]

Boris Johnson announces move to Covid Plan B

Prime Minister Boris Johnson announces a move to Plan B to tackle the Omicron variant of coronavirus. The measures include working from home, where possible, the implementation of Covid health certificates in nightclubs and mandatory mask wearing in cinemas and theatres. Report by Blairm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 02:09Published
Daughter of Covid victim reacts to Downing St party video [Video]

Daughter of Covid victim reacts to Downing St party video

Jacqueline Green speaks emotionally about how her mother Beryl died on the same day as an alleged Christmas party was held at Downing Street during Covid lockdown in December 2020. Jacqueline says "it is not enough to apologise now" and calls for Prime Minister Boris Johnson to "resign". Report by Blairm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:31Published

Pfizer Pfizer American multinational pharmaceutical corporation

Pfizer Says Its Booster Provides Protection Against Omicron Variant [Video]

Pfizer Says Its Booster Provides Protection Against Omicron Variant

Pfizer Says Its Booster Provides , Protection Against Omicron Variant. Pfizer Says Its Booster Provides , Protection Against Omicron Variant. NBC News reports officials with Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant. NBC News reports officials with Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant. Research shows their booster shot offers a similar degree of protection as two regular doses of their vaccine does against the original COVID-19 strain. Three doses against Omicron are almost equivalent to the two doses effectiveness we had against the... original variant. , Albert Bourla, CEO Pfizer, via NBC News. Lab tests suggest two doses of the Pfizer-BioNTech vaccine experience a 25-fold drop in efficacy when matched against the Omicron strain. An independent study showed the Pfizer vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies. . An independent study showed the Pfizer vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies. . Officials say these results are preliminary. More data will be necessary. Initially found in South Africa, the heavily-mutated Omicron variant is quickly spreading around the globe. Initially found in South Africa, the heavily-mutated Omicron variant is quickly spreading around the globe. Pfizer says it has begun work on an Omicron-specific vaccine. According to officials it could be ready in around 100 days. If we need a new vaccine, those tests are telling me we will be able to have a very good one if we need one. , Albert Bourla, CEO Pfizer, via NBC News. The current booster will maintain protection, but if we need one, we will make one and we will have it by March. , Albert Bourla, CEO Pfizer, via NBC News . The current booster will maintain protection, but if we need one, we will make one and we will have it by March. , Albert Bourla, CEO Pfizer, via NBC News

Credit: Wibbitz Top Stories    Duration: 01:30Published

Three doses of Pfizer vaccine can 'neutralise' Omicron variant, lab test shows

Three shots of the Pfizer/BioNTech COVID-19 vaccine has been shown to generate a neutralising effect against the new Omicron variant in a laboratory test.
Sky News

'Just do it': Margaret Keenan's message one year after receiving first COVID jab

The grandmother who made history when she got the Pfizer COVID jab exactly a year ago has urged anyone still to get vaccinated to "just do it" and help save..
Sky News

Pfizer vaccine may be up to 40 times less effective against Omicron, first lab tests in South Africa suggest

The Pfizer vaccine may be up to 40 times less effective against Omicron than the original COVID strain, the first lab tests on the new variant in South Africa..
Sky News

Antibodies from Pfizer vaccine may be up to 40 times less effective against Omicron, first lab tests suggest

The Pfizer vaccine may be up to 40 times less effective against Omicron than the original COVID strain, the first lab tests on the new variant in South Africa..
Sky News

Oneindia Oneindia.com is an Indian online portal

Madhulika Rawat, Wife of late CDS Bipin Rawat, Know more about her | Oneindia News [Video]

Madhulika Rawat, Wife of late CDS Bipin Rawat, Know more about her | Oneindia News

The wife of Chief of Defense staff Bipin Rawat, Madhulika Rawat, was onboard with him on the helicopter that crashed in Tamil Nadu. Know more about Madhulika Rawat. #CDSBipinRawat #MadullikaRawat #AWWA

Credit: Oneindia    Duration: 01:37Published
CDS Bipin Rawat’s chopper crashes in Tamil Nadu; Rahul Gandhi among others react | Oneindia News [Video]

CDS Bipin Rawat’s chopper crashes in Tamil Nadu; Rahul Gandhi among others react | Oneindia News

An Indian army helicopter that was carrying 14 passengers including Chief of Defence Staff General Bipin Rawat crashed in Tamil Nadu today. Civil Aviation minister Jyotiraditya Scindia, Congress leader Rahul Gandhi reacted to the incident on Twitter. #BipinRawat #RahulGandhi #ChopperCrash

Credit: Oneindia    Duration: 01:43Published
UP Election 2022: Congress releases ‘Women Manifesto’, promises Smartphone & Scooty | Oneindia News [Video]

UP Election 2022: Congress releases ‘Women Manifesto’, promises Smartphone & Scooty | Oneindia News

Ahead of the Uttar Pradesh assembly elections slated to happen early next year, Congress’s Uttar Pradesh General Secretary Priyank Gandhi Vadra released the party’s women manifesto on Wednesday. The manifesto promises smartphones and scooty to women, plus it also says that the grand old party will provide healthcare benefits to the women of the state. #Congress #WomenManifesto #UttarPradeshElection

Credit: Oneindia    Duration: 01:41Published
Munawar Faruqui dropped from Gurugram Comedy Festival after organizers get threat | Oneindia News [Video]

Munawar Faruqui dropped from Gurugram Comedy Festival after organizers get threat | Oneindia News

Controversial Standup comedian Munawar Faruqui once again felt the heat of right-wing when he was dropped from a show in Gurugram after the organizers alleged that they received threat calls. #MunawarFaruqui #GurugramComedyFestival #BJP

Credit: Oneindia    Duration: 01:31Published
Centre reportedly offers 'immediate suspension' of cases on farmers in a meeting | Oneindia News [Video]

Centre reportedly offers 'immediate suspension' of cases on farmers in a meeting | Oneindia News

Today, in a fresh proposal to protesting farmers, the Centre has reportedly offered ‘immediate suspension’ of all cases against them. #SKM #Centre #FarmersProtest

Credit: Oneindia    Duration: 01:19Published

BioNTech BioNTech German biotechnology company

Greta Thunberg and Angela Merkel triumph at the Women of Europe Awards [Video]

Greta Thunberg and Angela Merkel triumph at the Women of Europe Awards

BioNTech founder Dr Özlem Türeci and grassroots activist Jenny Rasche were also recognised for their work.

Credit: euronews (in English)    Duration: 02:16Published

BioNTech boss says 'don't freak out' about Omicron as Pfizer jab likely to protect against severe COVID

The Pfizer vaccine is likely to offer strong protection against any severe disease from the new Omicron COVID variant, according to the head of BioNTech who..
Sky News

Pfizer–BioNTech COVID-19 vaccine Pfizer–BioNTech COVID-19 vaccine mRNA-based COVID-19 vaccine

Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says study

Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the..
IndiaTimes

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill [Video]

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill

FDA Advisers Narrowly Endorse , Merck’s COVID Antiviral Pill. On Nov. 30, the FDA's Antimicrobial Drugs Advisory Committee voted to endorse Merck's molnupiravir pill for use in treating COVID-19 in high-risk adults. On Nov. 30, the FDA's Antimicrobial Drugs Advisory Committee voted to endorse Merck's molnupiravir pill for use in treating COVID-19 in high-risk adults. The vote was 13-10. The panel's decision could prompt the agency to grant Merck emergency use authorization, which the U.K. has already done. CBS News reports the Biden administration has already bought about 3.1 million courses of the treatment, which is given to patients over five days. CBS News reports the Biden administration has already bought about 3.1 million courses of the treatment, which is given to patients over five days. This is the first opportunity that an oral outpatient medication for mildly symptomatic to moderate symptomatic persons would be available, Dr. W. David Hardy, a scientist at Charles Drew University School of Medicine and Science and panel member, via CBS News. Those in opposition debated the rare risk that the drug, which relies on triggering mutations of the virus, might unleash a new variant. Even if the probability is very low, one in 10,000 to one in 100,000, that this drug would induce an escape mutant for which the vaccines we have do not cover, that would be catastrophic for the whole world actually, Dr. James Hildreth, one of the panel's advisers, via CBS News. CBS News reports Merck admitted it did not have the data to accurately estimate that risk, but no one who took the pills appeared to be infectious. Additionally, Merck's most recent trial data revealed a 30% efficacy rate as opposed to its initial claim of reducing the risk of hospitalization or death by 50%. Additionally, Merck's most recent trial data revealed a 30% efficacy rate as opposed to its initial claim of reducing the risk of hospitalization or death by 50%

Credit: Wibbitz Top Stories    Duration: 01:30Published
Vaccine Expert: Everyone on FDA panel would vaccinate their own child [Video]

Vaccine Expert: Everyone on FDA panel would vaccinate their own child

Dr. Paul Offit, pediatrician, vaccine pioneer and author of “You Bet Your Life,” explains the risk inherent in every major medical breakthrough

Credit: Bleacher Report AOL    Duration: 10:12Published
FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11 [Video]

FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11

CNN’s Nick Watt reports.

Credit: Bleacher Report AOL    Duration: 02:49Published
The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11 [Video]

The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11

Dr. Lee Savio Beers discusses with CNN’s Jake Tapper.

Credit: Bleacher Report AOL    Duration: 04:18Published

Related videos from verified sources

CCISD ranks fifth for most new COVID-19 cases among Texas school districts [Video]

CCISD ranks fifth for most new COVID-19 cases among Texas school districts

The Corpus Christi Independent School District, like many other Texas school districts, is seeing a significant rise in COVID-19 cases during the recent spike.

Credit: Kris 6 News     Duration: 00:34Published
New Milestone: 80% Of Californians Receive At Least 1 COVID-19 Shot [Video]

New Milestone: 80% Of Californians Receive At Least 1 COVID-19 Shot

Gov. Gavin Newsom says 80% of all eligible Californians have gotten at least one dose of the COVID-19 vaccine. Serene Branson reports.

Credit: KCAL 9 CBS LA     Duration: 00:35Published
Study: Moderna's COVID Vaccine Produces Twice The Antibodies Of Pfizer's [Video]

Study: Moderna's COVID Vaccine Produces Twice The Antibodies Of Pfizer's

A new study is out comparing the COVID vaccine from Cambridge-based biotech company Moderna to the one developed by Pfizer.

Credit: WBZ CBS Boston     Duration: 01:05Published